NCT01986634

Brief Summary

Perioral rhytides present a difficult problem in facial rejuvenation. They cannot be addressed with rhytidectomy (face lift) and direct excision can leave visible unfavorable scars. Currently, fine static wrinkles are most effectively treated with facial resurfacing, usually with laser treatment. Often the peri-oral area is treated with additional spot treatments with an ablative laser to cause a more robust healing response and better aesthtic result. To date, no studies have specifically shown efficacy of additional spot treatment over full facial laser alone. This study is designed as a split-face study, to compare the aesthetic results of full field laser resurfacing on one half of the face with that of spot treatment of perioral rhytides on the other half. To clarify further to the IRB board, this is not an experimental treatment. Spot treatment is used by many surgeons/laser proceduralists for addressing specific areas of the face. This is an FDA indicated use of the laser for facial resurfacing. Due to the many genetic and enviromental factors that can effect the results the best design for the study to is have each patient serve as their own control with a split-face study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 18, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2014

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
Last Updated

July 5, 2023

Status Verified

June 1, 2023

Enrollment Period

12 months

First QC Date

November 11, 2013

Last Update Submit

June 30, 2023

Conditions

Keywords

Laser ResurfacingRhytidsPerioral

Outcome Measures

Primary Outcomes (1)

  • Improvement in perioral rhytids

    at 3 and 6 month post-operative visits, photographs will be taken and analyzed for improvement in rhytids.

    3-6 months

Secondary Outcomes (1)

  • Time to healing after laser resurfacing

    2-3 weeks

Study Arms (1)

Laser Treatment

OTHER

Patients enrolled will have split face laser treatment. Patients will serve as their own control.

Procedure: Laser Treatment

Interventions

Patient will have split face laser resurfacing as per standard of care. One side of the face will be treated with a standardized single depth laser peel. The other side of the perioral area will be treated with variant, deeper treatment to perioral rhytids.

Laser Treatment

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who are electively presenting to the plastic surgery department for evaluation and treatment of facial aging and elect/seek to have laser treatment will be asked to voluntarily participate in the study.
  • Fitzpatrick type 1-4 skin

You may not qualify if:

  • Patients undergoing additional invasive cosmetic procedure at the same time including rhytidectomy, fat injection
  • History of Photosensitvity
  • Use of photosenstive medications
  • History of keloid or hypertrophic scarring
  • Use of Isotretinoin in the previous year
  • Previous resurfacing procedure (laser or chemical peel) within the previous 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univeristy Hospitals Cedar Brainard Office

Lyndhurst, Ohio, 44124, United States

Location

MeSH Terms

Interventions

Laser Therapy

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • David J Rowe, MD

    University Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2013

First Posted

November 18, 2013

Study Start

September 1, 2013

Primary Completion

August 31, 2014

Study Completion

December 31, 2015

Last Updated

July 5, 2023

Record last verified: 2023-06

Locations